Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome

Journal of Radiological Protection

Volumn 30, Issue 4, 2010, Pages 687-698

  Stickney, Dwight R ^a   Groothuis, Jessie R ^a   Ahlem, Clarence ^a   Kennedy, Mike ^a   Miller, Barry S ^a   Onizuka Handa, Nanette ^a   Schlangen, Karen M ^a   Destiche, Daniel ^a   Reading, Chris ^a   Garsd, Armando ^a   Frincke, James M ^a  

^a Harbor Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RADIATION SYNDROME; ADAPTIVE IMMUNITY; ADVERSE EVENTS; ANIMAL MODEL; AQUEOUS SUSPENSIONS; BLOOD CHEMISTRY; BLOOD CONCENTRATIONS; C-REACTIVE PROTEINS; DOSE RESPONSE RELATIONSHIPS; DOSE-VOLUME; IMMUNE SUPPRESSION; INNATE IMMUNITY; INTRAMUSCULAR INJECTIONS; NEUTROPENIA; PARENTERAL ADMINISTRATION; PERIPHERAL BLOOD; RADIATION-INDUCED; THROMBOCYTOPENIA;

BLOOD;

SUSPENSIONS (FLUIDS);

ANDROSTENEDIOL;

ACUTE RADIATION SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACUTE RADIATION SYNDROME; ADULT; AGED; ANDROSTENEDIOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 78650325325     PISSN: 09524746     EISSN: 13616498     Source Type: Journal    
DOI: 10.1088/0952-4746/30/4/004     Document Type: Article

References (54)

1. Hall E J 1988 Radiobiology for the Radiologist ed P O'Kane (Philadelphia, PA: Lippincott) pp 365-76
2. Cerveny T J, MacVittie T J and Young RW1989 Acute radiation syndrome in humansMedical Consequences of Nuclear Warfare ed R I Walker and T J Cerveny (Falls Church, VA: Office of the Surgeon General) pp 15-36
3. Webster J I, Tonelli L and Sternberg E M 2002 Neuroendocrine regulation of immunity Annu. Rev. Immunol. 20 125-63
4. Berczi I 1998 The stress concept and neuroimmunoregulation in modern biology Ann. New York Acad. Sci. 851 3-12
5. Daynes R A, Araneo B A, Hennebold J, Enioutina E and Mu H H 1995 Steroids as regulators of the mammalian immune response J. Invest. Dermatol. 105 14S-9S
6. Grafte-Faure S, Leveque C, Vasse M, Soria C, Norris V and Vannier J P 1999 Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells Am. J. Hematol. 62 65-73
7. Croisille L, Auffray I, Katz A, Izac B, Vainchenker W and Coulombel L 1994 Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells Blood 84 4116-24
8. Risdon G, Kumar V and Bennett M 1991 Differential effects of dehydroepiandrosterone (DHEA) on murine lymphopoiesis and myelopoiesis Exp. Hematol. 19 128-31
9. Risdon G, Moore T A, Kumar V and Bennett M 1991 Inhibition of murine natural killer cell differentiation by dehydroepiandrosterone Blood 78 2387-91
10. Lavallee B, Provost P R, Roy R, Gauthier M C and Belanger A 1996 Dehydroepiandrosterone-fatty acid esters in human plasma: Formation, transport and delivery to steroid target tissues J. Endocrinol. 150 (Suppl.) S119-24
11. Legrain S and Girard L 2003 Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects Drugs Aging 20 949-67
12. Legrain S et al 2000 Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects J. Clin. Endocrinol. Metab. 85 3208-17
13. Bird C E, Murphy J, Boroomand K, Finnis W, Dressel D and Clark A F 1978 Dehydroepiandrosterone: Kinetics of metabolism in normal men and women J. Clin. Endocrinol. Metab. 47 818-22
14. Marwah A, Marwah P and Lardy H 2002 Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: A liquid chromatographic-mass spectrometric study J. Chromatogr. B 767 285-99
15. Bird C E, Morrow L, Fukumoto Y, Marcellus S and Clark A F 1976 Delta5-androstenediol: Kinetics of metabolism and binding to plasma proteins in normal men and women J. Clin. Endocrinol. Metab. 43 1317-22
16. Loria R M, Padgett D A and Huynh P N 1996 Regulation of the immune response by dehydroepiandrosterone and its metabolites J. Endocrinol. 150 (Suppl.) S209-20
17. Loria R M and Padgett D A 1998 Control of the immune response by DHEA and its metabolites Rinsho Byori. 46 505-17
18. Padgett D A, Loria R M and Sheridan J F 1997 Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol J. Neuroimmunol. 78 203-11
19. Padgett D A and Sheridan J F 1999 Androstenediol (AED) prevents neuroendocrine-mediated suppression of the immune response to an influenza viral infection J. Neuroimmunol. 98 121-9
20. Padgett D A, Loria R M and Sheridan J F 2000 Steroid hormone regulation of antiviral immunity Ann. New York Acad. Sci. 917 935-43
21. Ben-Nathan D, Padgett D A and Loria R M 1999 Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity J. Med. Microbiol. 48 425-31
22. Loria R M and Padgett D A 1992 Androstenediol regulates systemic resistance against lethal infections in mice Arch. Virol. 127 103-15
23. Padgett D A and Loria R M 1994 In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol J. Immunol. 153 1544-52
24. Loria R M and Padgett D A 1992 Mobilization of cutaneous immunity for systemic protection against infections Ann. New York Acad. Sci. 650 363-6
25. Whitnall M H, Elliott T B, Ledney G D, Landauer M R, Jackson W E and Loria R M 1997 Androstenediol stimulates myelopoiesis but not lymphopoiesis in irradiated mice Blood 90 175a
26. Whitnall M H, Inal C E, Jackson W E III, Miner V L, Villa V and Seed T M 2001 In vivo radioprotection by 5-androstenediol: stimulation of the innate immune system Radiat. Res. 156 283-93
27. WhitnallM H et al 2000 Androstenediol stimulates myelopoiesis and enhances resistance to infection in gammairradiated mice Int. J. Immunopharmacol. 22 1-14
28. XiaoM, Inal C E, Parekh V I, Chang CMand WhitnallMH 2007 5-androstenediol promotes survival of gammairradiated human hematopoietic progenitors through induction of nuclear factor-γB activation and granulocyte colony-stimulating factor expression Mol. Pharmacol. 72 370-9
29. Singh V Ket al 2008 Administration of 5-androstenediol to mice: Pharmacokinetics and cytokine gene expression Exp. Mol. Pathol. 84 178-88
30. Whitnall MH, Villa V, Benjack J, Miner V L, Seed T M and JacksonWE 3rd 2002 Effects of the novel systemic radioprotectant 5-androstenediol of phagocytosis and oxidative burst in monocytes and granulocytes from mice exposed to whole-body gamma irradiation 49th Ann. Mtg of the Radiation Research Society (Reno, NV, April 2002)
31. Aerts Kaya F S F, Visser T P, Arshad S, Frincke J, Stickney D R, Reading C L and Wagemaker G 2009 5- androstene-3β, 17β-diol promotes reconstitution of immature hematopoietic cells following myelosuppressive radiation and strongly synergizes with thrombopoietin, submitted
32. Segaloff A, Horwitt B N, Gordon D, Murison P J and Schlosser J V 1952 Hormonal therapy in cancer of the breast. IV. Effect of androstenediol on clinical course and hormonal excretion Cancer 5 1179-81
33. Stickney D R, Dowding C, Garsd A, Ahlem C, Whitnall M, McKeon M, Reading C and Frincke J 2006. 5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression Int. Immunopharmacol. 6 1706-13
34. Stickney D R, Dowding C, Authier S, Garsd A, Onizuka-Handa N, Reading C and Frincke J 2007. 5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression Int. Immunopharmacol. 7 500-5
35. Aerts Kaya F S F, Arshad S, Visser T P, Stickney D R, Frincke J M, Verstegen M M A, Reading C L and Wagemaker G 2009 5-androstene-3 beta, 17 beta-diol after total body irradiation of rhesus monkeys promotes recovery of hematopoietic stem cells and progenitor cells, submitted
36. Perrier D and Gibaldi M 1982 General derivation of the equation for time to reach a certain fraction of steady state J. Pharm. Sci. 71 474-5
37. Westfall P H, Tobias R D, Rom D,Wolfinger R D and Hochberg Y 1999 Additional topics Multiple Comparisons and Multiple Tests Using the SAS® System (Cary, NC: SAS) pp 121-33
38. ConoverW J 1999 Practical Nonparametric Statistics (New York: Wiley) pp 325-7
39. Walker G A 1997 Common Statistical Methods for Clinical Research with SAS® Examples (Cary, NC: SAS) pp 159-67
40. Labrie F, Belanger A, Cusan L, Gomez J L and Candas B 1997 Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging J. Clin. Endocrinol. Metab. 82 2396-402
41. Blizzard T A et al 2006 Androstenediol analogs as ER-beta-selective SERMs Bioorg.Med. Chem. Lett. 16 834-8
42. Koehler K F, Helguero L A, Haldosen L A, WarnerM and Gustafsson J A 2005 Reflections on the discovery and significance of estrogen receptor beta Endocr. Rev. 26 465-78
43. Bertho J M, Frick J, Prat M, Demarquay C, Dudoignon N, Trompier F, Gorin N C, Thierry D and Gourmelon P 2005 Comparison of autologous cell therapy and granulocyte-colony stimulating factor (GCSF) injection versus G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model Int. J. Radiat. Oncol. Biol. Phys. 63 911-20
44. Tanikawa S, Nose M, Aoki Y, Tsuneoka K, Shikita M and Nara N 1990 Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice Blood 76 445-9
45. Tanikawa S, Nakao I, Tsuneoka K and Nara N 1989 Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice Exp. Hematol. 17 883-8
46. Neelis K J, Hartong S C, Egeland T, Thomas G R, Eaton D L and Wagemaker G 1997 The efficacy of singledose administration of thrombopoietinwith coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys Blood 90 2565-73
47. Borge O J, Ramsfjell V, Cui L and Jacobsen S E 1997 Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38-bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin Blood 90 2282-92
48. Borge O J, Ramsfjell V, Veiby O P, Murphy M J Jr, Lok S and Jacobsen S E 1996 Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro Blood 88 2859-70
49. Bodey G P, Buckley M, Sathe Y S and Freireich E J 1966 Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann. Intern. Med. 64 328-40
50. Crawford J et al 1991 Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer N. Engl. J. Med. 325 164-70
51. Klinger M H 1997 Platelets and inflammation Anat. Embryol. (Berl) 196 1-11
52. Klinger M H and Jelkmann W 2002 Role of blood platelets in infection and inflammation J. Interferon Cytokine Res. 22 913-22
53. Nachman R L and Weksler B 1972 The platelet as an inflammatory cell Ann. New York Acad. Sci. 201 131-7
54. Koo S P, Yeaman M R and Bayer A S 1996 Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase Infect Immun. 64 3758-64